vs
CVRx, Inc.（CVRX）与Stran & Company, Inc.（SWAG）财务数据对比。点击上方公司名可切换其他公司
Stran & Company, Inc.的季度营收约是CVRx, Inc.的1.8倍（$28.9M vs $16.0M），Stran & Company, Inc.净利率更高（0.8% vs -74.5%，领先75.3%），Stran & Company, Inc.同比增速更快（7.2% vs 4.4%），Stran & Company, Inc.自由现金流更多（$38.0K vs $-9.8M），过去两年Stran & Company, Inc.的营收复合增速更高（24.0% vs 22.0%）
CVRx, Inc.是一家处于商业化阶段的医疗科技企业，专注于慢性心血管疾病神经调节疗法的研发与商业化，旗舰产品Barostim系统用于治疗心力衰竭和难治性高血压，核心市场覆盖北美、欧洲，服务对常规药物治疗应答不佳的患者。
Stran & Company, Inc.是品牌促销产品、定制周边及一体化营销解决方案供应商，服务覆盖零售、医疗、科技、教育等领域企业客户，助力客户开展品牌宣传、用户运营及员工激励相关工作。
CVRX vs SWAG — 直观对比
营收规模更大
SWAG
是对方的1.8倍
$16.0M
营收增速更快
SWAG
高出2.8%
4.4%
净利率更高
SWAG
高出75.3%
-74.5%
自由现金流更多
SWAG
多$9.9M
$-9.8M
两年增速更快
SWAG
近两年复合增速
22.0%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $16.0M | $28.9M |
| 净利润 | $-11.9M | $243.0K |
| 毛利率 | 86.3% | 30.4% |
| 营业利润率 | -69.8% | -0.1% |
| 净利率 | -74.5% | 0.8% |
| 营收同比 | 4.4% | 7.2% |
| 净利润同比 | -12.0% | 141.5% |
| 每股收益（稀释后） | $-0.45 | $0.02 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CVRXSWAG
| Q4 25 | $16.0M | $28.9M | ||
| Q3 25 | $14.7M | $26.0M | ||
| Q2 25 | $13.6M | $32.6M | ||
| Q1 25 | $12.3M | $28.7M | ||
| Q4 24 | $15.3M | $27.0M | ||
| Q3 24 | $13.4M | $20.1M | ||
| Q2 24 | $11.8M | $16.7M | ||
| Q1 24 | $10.8M | $18.8M |
净利润CVRXSWAG
| Q4 25 | $-11.9M | $243.0K | ||
| Q3 25 | $-12.9M | $-1.2M | ||
| Q2 25 | $-14.7M | $643.0K | ||
| Q1 25 | $-13.8M | $-393.0K | ||
| Q4 24 | $-10.7M | $-586.0K | ||
| Q3 24 | $-13.1M | $-2.0M | ||
| Q2 24 | $-14.0M | $-1.0M | ||
| Q1 24 | $-22.2M | $-491.0K |
毛利率CVRXSWAG
| Q4 25 | 86.3% | 30.4% | ||
| Q3 25 | 86.8% | 27.2% | ||
| Q2 25 | 84.3% | 30.3% | ||
| Q1 25 | 83.5% | 29.6% | ||
| Q4 24 | 83.2% | 32.5% | ||
| Q3 24 | 83.2% | 29.5% | ||
| Q2 24 | 83.9% | 32.8% | ||
| Q1 24 | 85.0% | 29.8% |
营业利润率CVRXSWAG
| Q4 25 | -69.8% | -0.1% | ||
| Q3 25 | -83.5% | -6.9% | ||
| Q2 25 | -105.8% | 1.2% | ||
| Q1 25 | -108.8% | -1.9% | ||
| Q4 24 | -67.0% | -3.5% | ||
| Q3 24 | -97.3% | -10.8% | ||
| Q2 24 | -118.3% | -6.6% | ||
| Q1 24 | -206.4% | -3.5% |
净利率CVRXSWAG
| Q4 25 | -74.5% | 0.8% | ||
| Q3 25 | -87.6% | -4.8% | ||
| Q2 25 | -108.4% | 2.0% | ||
| Q1 25 | -111.5% | -1.4% | ||
| Q4 24 | -69.4% | -2.2% | ||
| Q3 24 | -98.0% | -10.1% | ||
| Q2 24 | -118.8% | -6.1% | ||
| Q1 24 | -206.0% | -2.6% |
每股收益（稀释后）CVRXSWAG
| Q4 25 | $-0.45 | $0.02 | ||
| Q3 25 | $-0.49 | $-0.07 | ||
| Q2 25 | $-0.57 | $0.03 | ||
| Q1 25 | $-0.53 | $-0.02 | ||
| Q4 24 | $-0.39 | $-0.02 | ||
| Q3 24 | $-0.57 | $-0.11 | ||
| Q2 24 | $-0.65 | $-0.06 | ||
| Q1 24 | $-1.04 | $-0.03 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $75.7M | $11.6M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $39.3M | $30.5M |
| 总资产 | $104.8M | $49.3M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资CVRXSWAG
| Q4 25 | $75.7M | $11.6M | ||
| Q3 25 | $85.1M | $11.8M | ||
| Q2 25 | $95.0M | $18.1M | ||
| Q1 25 | $102.7M | $12.2M | ||
| Q4 24 | $105.9M | $18.2M | ||
| Q3 24 | $100.2M | $6.9M | ||
| Q2 24 | $70.4M | $9.6M | ||
| Q1 24 | $80.1M | $10.7M |
股东权益CVRXSWAG
| Q4 25 | $39.3M | $30.5M | ||
| Q3 25 | $48.1M | $30.2M | ||
| Q2 25 | $57.9M | $31.8M | ||
| Q1 25 | $71.1M | $31.3M | ||
| Q4 24 | $71.1M | $31.6M | ||
| Q3 24 | $65.2M | $32.3M | ||
| Q2 24 | $55.2M | $34.3M | ||
| Q1 24 | $66.3M | $35.2M |
总资产CVRXSWAG
| Q4 25 | $104.8M | $49.3M | ||
| Q3 25 | $111.3M | $50.3M | ||
| Q2 25 | $119.6M | $61.2M | ||
| Q1 25 | $129.6M | $52.2M | ||
| Q4 24 | $133.4M | $55.1M | ||
| Q3 24 | $127.7M | $48.8M | ||
| Q2 24 | $96.0M | $46.6M | ||
| Q1 24 | $106.2M | $47.9M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-9.8M | $161.0K |
| 自由现金流经营现金流 - 资本支出 | $-9.8M | $38.0K |
| 自由现金流率自由现金流/营收 | -61.3% | 0.1% |
| 资本支出强度资本支出/营收 | 0.4% | 0.4% |
| 现金转化率经营现金流/净利润 | — | 0.66× |
| 过去12个月自由现金流最近4个季度 | $-40.8M | $-5.5M |
8季度趋势，按日历期对齐
经营现金流CVRXSWAG
| Q4 25 | $-9.8M | $161.0K | ||
| Q3 25 | $-9.7M | $-5.4M | ||
| Q2 25 | $-7.9M | $6.4M | ||
| Q1 25 | $-12.8M | $-5.9M | ||
| Q4 24 | $-8.0M | $1.3M | ||
| Q3 24 | $-10.4M | $-2.7M | ||
| Q2 24 | $-9.8M | $2.1M | ||
| Q1 24 | $-10.9M | $2.1M |
自由现金流CVRXSWAG
| Q4 25 | $-9.8M | $38.0K | ||
| Q3 25 | $-10.0M | $-5.9M | ||
| Q2 25 | $-8.0M | $6.3M | ||
| Q1 25 | $-12.9M | $-6.0M | ||
| Q4 24 | $-8.1M | $1.2M | ||
| Q3 24 | $-10.4M | $-2.9M | ||
| Q2 24 | $-10.2M | $1.9M | ||
| Q1 24 | $-11.8M | $1.9M |
自由现金流率CVRXSWAG
| Q4 25 | -61.3% | 0.1% | ||
| Q3 25 | -68.1% | -22.6% | ||
| Q2 25 | -59.2% | 19.5% | ||
| Q1 25 | -104.3% | -21.0% | ||
| Q4 24 | -52.5% | 4.6% | ||
| Q3 24 | -78.1% | -14.3% | ||
| Q2 24 | -86.3% | 11.6% | ||
| Q1 24 | -109.7% | 9.9% |
资本支出强度CVRXSWAG
| Q4 25 | 0.4% | 0.4% | ||
| Q3 25 | 2.0% | 1.9% | ||
| Q2 25 | 0.8% | 0.2% | ||
| Q1 25 | 0.9% | 0.4% | ||
| Q4 24 | 0.3% | 0.3% | ||
| Q3 24 | 0.3% | 0.7% | ||
| Q2 24 | 3.0% | 1.1% | ||
| Q1 24 | 8.5% | 1.0% |
现金转化率CVRXSWAG
| Q4 25 | — | 0.66× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 9.99× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CVRX
| US | $14.9M | 93% |
| Other | $1.1M | 7% |
SWAG
| Promotional Products Dropshipping | $11.2M | 39% |
| Casino Continuity Program | $6.9M | 24% |
| Promotional Products Company Owned Inventory | $4.6M | 16% |
| Promotional Products Bulk Dropshipping | $3.8M | 13% |
| Promotional Products Thirdparty Distributor | $1.8M | 6% |
| Other | $610.0K | 2% |
